Drug maker GlaxoSmithKline. is about to face as many as 16 lawsuit for the diabetes drug Avandia. The lwsuit charges that the mentioned drug has elst many of the diabetes patients more injured or even led to death. Fifteen of the suits were filed in the Beaumont Division of the Eastern District of Texas, while one was filed in the Lufkin Division. All the 16-page suits were filed on Aug. 18 and Aug. 19.
To describe, the lawsuit charges the drug maker of a defective and dangerous pharmaceutical product, Avandia, which was manufactured, marketed, distributed and/or sold by GlaxoSmithKline to the general public. The lawsuit was filed by the Provost Umprhey attorney Chris Kirchmer. Each suit seeks damages in excess of $75,000.
Avandia, also known as Rosiglitazone, was initially approved by the U.S. Food and Drug Administration as safe and effective for treating diabetes mellitus type 2. Type 2 diabetes occurs when the body fails to properly use insulin, which is made in the pancreas to help cells use sugar from the bloodstream.
GSK was aware of numerous reports of congestive attacks, strokes and other serious cardiovascular injuries and death associated with Avandia, the suits allege. The lawsuit is said to have backed by the separate studies that show Avandia increases the risk of cardiovascular injury.
The suits claim that instead of warning the public about the risk, GSK attempted to “silence Dr. Buse by threatening him with a $4 million lawsuit and by characterizing him as a liar according to his testimony before Congress.”
Source: The Record
Filed under Class Action, Medical Malpractice | Tags: Avandia., cardiovascular injury., Claim, Damages, diabetes mellitus type 2., diabetes., GlaxoSmithKline, Insulin, Provost Umprhey attorney, Texas. | 1 Comment